This paper considers the potential value of genomic information, comments on the nature of evidence about this potential value, particularly on genetic association studies, points out the need for a roadmap, outlines steps in a roadmap that was developed within the Human Genome Epidemiology Network (HuGENet), discusses progress with these steps, and comments on future directions.
Department of Epidemiology and Community Medicine
University of Ottawa, 451 Smyth Rd
Ottawa, Ont. K1H 8M5 (Canada)
Tel. +1 613 562 5800 ext. 8159, Fax +1 613 562 5465, E-Mail firstname.lastname@example.org
Published online: April 15, 2010
Number of Print Pages : 11
Number of Figures : 0, Number of Tables : 3, Number of References : 110
Public Health Genomics
Vol. 13, No. 4, Year 2010 (Cover Date: April 2010)
Journal Editor: Knoppers B.M. (Montreal, Que.), Brand A. (Maastricht), Burke W. (Seattle, Wash.), Khoury M.J. (Atlanta, Ga.)
ISSN: 1662-4246 (Print), eISSN: 1662-8063 (Online)
For additional information: http://www.karger.com/PHG
Article / Publication Details
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.